The Financial Burden of Patient Comorbidities on Total Hip Arthroplasties—A Matched Cohort Analysis of High Comorbidity Burden and Non–High Comorbidity Burden Patients

The impact of increased patient comorbidities on the cost-effectiveness of total hip arthroplasty (THAs) is lacking. This study aimed to compare revenue, costs, and short-term (90 days) surgical outcomes between patients who have and do not have a high comorbidity burden (HCB). We retrospectively re...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Journal of arthroplasty 2024-09, Vol.39 (9), p.S29-S33
Hauptverfasser:	Ashkenazi, Itay, Thomas, Jeremiah, Katzman, Jonathan, Meftah, Morteza, Davidovitch, Roy, Schwarzkopf, Ran
Format:	Artikel
Sprache:	eng
Schlagworte:	contribution margin direct cost high-comorbidity patients patient revenue total cost
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!